Note: Molecular Epidemiology's revenues are gauged from an analysis of company filings.
Molecular Epidemiology's Income Statement (based on Industry Averages)
Molecular Epidemiology P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Molecular Epidemiology is developing and marketing.
Molecular Epidemiology doesn't have any recent trademark applications, indicating Molecular Epidemiology is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
TESTED FOOD Food safety testing and consultation
05/20/2008
N360 TESTING Testing of raw materials; Food safety testing and consultation; Material testing
04/23/2008
N360 TEST Food safety testing and consultation; Material testing; Testing of raw materials
04/23/2008
See all trademarks and details in the Full Report.
Market Share of Molecular Epidemiology's Largest Competitors
A competitive analysis shows these companies are in the same general field as Molecular Epidemiology, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Molecular Epidemiology.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Molecular Epidemiology and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.